LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) announced today financial results for the three and nine months ended June 30, 2008. The Company reported a net loss of $580,000, or $0.02 per share, compared to a loss of $509,000, or $0.02 per share, for the three months ended June 30, 2007, an increase of 14%.
